Glaucoma News

ORLANDO — In this Healio Video Perspective from Telling It Like It Is, I. Paul Singh, MD, discusses utilizing the “robust” portfolio of technologies and devices to shift to an interventional glaucoma mindset.

ORLANDO — In this Healio Video Perspective from Telling It Like It Is, Steven M. Silverstein, MD, FACS, discusses the positive impact of Dextenza on inflammation after intraocular surgery.

KOLOA, Hawaii — In this Healio Video Perspective from Hawaiian Eye 2025, I. Paul Singh, MD, discusses the AquaLumen, a subconjunctival bypass technology to lower IOP in patients with glaucoma.

KOLOA, Hawaii — In this Healio Video Perspective from Hawaiian Eye 2025, I. Paul Singh, MD, discusses the benefits of using AlloFlo to create a cyclodialysis cleft in patients with glaucoma.

Patients with primary open-angle glaucoma or ocular hypertension who received QLS-111 experienced lower IOP in two phase 2 trials, according to a press release from Qlaris Bio.

Adam Szaronos has been appointed as CEO of Iantrek, succeeding Sean Ianchulev, MD, MPH, according to a press release.

Among patients with suspected or confirmed glaucoma, higher average blood pressure and greater variability in blood pressure were associated with faster visual field loss, according to a study published in JAMA Ophthalmology.

KOLOA, Hawaii — In this Healio Video Perspective from Hawaiian Eye 2025, I. Paul Singh, MD, explains excimer laser trabeculostomy for the treatment of glaucoma.

Older adults who participated in time-restricted fasting by skipping breakfast were not at reduced risk for glaucoma compared with individuals who did not fast, according to a study published in Journal of Glaucoma.